These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23787355)

  • 1. Reply to Samuel Bishara and Jim Adshead's letter to the editor re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45.
    Linder BJ; Boorjian SA
    Eur Urol; 2013 Sep; 64(3):e49-50. PubMed ID: 23787355
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45.
    Bishara S; Adshead J
    Eur Urol; 2013 Sep; 64(3):e48. PubMed ID: 23769589
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71. Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?
    Bochner BH; Dalbagni G
    Eur Urol; 2019 May; 75(5):e138-e139. PubMed ID: 30712972
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399-405.
    Nguyen DP; Scherr DS
    Eur Urol; 2016 Mar; 69(3):e36. PubMed ID: 26187784
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting.
    Vetterlein MW; Rink M
    Eur Urol; 2020 Jan; 77(1):e12-e13. PubMed ID: 31607396
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.
    Gschwend JE; Heck M
    Eur Urol; 2019 Aug; 76(2):e37. PubMed ID: 31056229
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Jim C. Hu, Bilal Chughtai, Padraic O'Malley, et al. Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study. Eur Urol 2016;70:195-202: Comparative Effectiveness of Robotic-assisted versus Open Radical Cystectomy: Big Data but Meaningful Conclusions?
    Williams SB; Ghaffary CK; Dafashy TJ; Orihuela E
    Eur Urol; 2017 Jan; 71(1):e14-e15. PubMed ID: 27292866
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
    Bhindi B; Boorjian SA
    Eur Urol; 2018 Mar; 73(3):e70-e71. PubMed ID: 29097100
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
    Vetterlein MW; Gild P; Fisch M; Rink M
    Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Georgios Papadopoulos, Charalampos Fragkoulis, and Konstantinos Ntoumas' Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
    Bhindi B; Boorjian SA
    Eur Urol; 2018 Mar; 73(3):e53. PubMed ID: 29246642
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9.
    Soria F; D'Andrea D; Gontero P; Shariat SF
    Eur Urol Focus; 2022 Mar; 8(2):633-634. PubMed ID: 33875390
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70.
    Mayr R; May M; Fritsche HM
    Eur Urol; 2013 Jan; 63(1):e10. PubMed ID: 23079054
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Vladimir Novotny, Manfred P. Wirth, Michael Froehner's letter to the editor re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163.
    Roghmann F; May M; Aziz A
    Eur Urol; 2014 Jul; 66(1):e14. PubMed ID: 24598014
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Hassan Abol-Enein, Derya Tilki, Ahmed Mosbah, et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 2011;60:572-7.
    Zhang H; Ye D
    Eur Urol; 2011 Nov; 60(5):e48. PubMed ID: 21807455
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Santhanam Sundar's letter to the editor Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-18.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA; Lebret T
    Eur Urol; 2012 Aug; 62(2):e45-6. PubMed ID: 22579356
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399-405.
    Pourmalek F; Abdi H; Black PC
    Eur Urol; 2016 Mar; 69(3):e35. PubMed ID: 26184973
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Syed Johar Raza, Timothy Wilson, James O. Peabody, et al. Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Eur Urol 2015;68:721-8.
    Froehner M; Koch R; Wirth MP
    Eur Urol; 2015 Nov; 68(5):e109. PubMed ID: 26144874
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.
    Taguchi S; Nakagawa T; Fukuhara H
    Eur Urol; 2019 Aug; 76(2):e35-e36. PubMed ID: 31054784
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply from Authors re: Girish S. Kulkarni, Zachary Klaassen. Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? Eur Urol 2017;72:488-9: Using the National Cancer Data Base to Compare Treatment Modalities for Localized Muscle-invasive Bladder Cancer.
    Seisen T; Cole AP; Trinh QD
    Eur Urol; 2017 Oct; 72(4):489-491. PubMed ID: 28571883
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65.
    Sun L; Feng Y
    Eur Urol; 2020 Jan; 77(1):e10-e11. PubMed ID: 31607395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.